Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Gut ; 68(1): 83-93, 2019 01.
Artigo em Inglês | MEDLINE | ID: mdl-29097438

RESUMO

OBJECTIVE: To investigate whether a whole grain diet alters the gut microbiome and insulin sensitivity, as well as biomarkers of metabolic health and gut functionality. DESIGN: 60 Danish adults at risk of developing metabolic syndrome were included in a randomised cross-over trial with two 8-week dietary intervention periods comprising whole grain diet and refined grain diet, separated by a washout period of ≥6 weeks. The response to the interventions on the gut microbiome composition and insulin sensitivity as well on measures of glucose and lipid metabolism, gut functionality, inflammatory markers, anthropometry and urine metabolomics were assessed. RESULTS: 50 participants completed both periods with a whole grain intake of 179±50 g/day and 13±10 g/day in the whole grain and refined grain period, respectively. Compliance was confirmed by a difference in plasma alkylresorcinols (p<0.0001). Compared with refined grain, whole grain did not significantly alter glucose homeostasis and did not induce major changes in the faecal microbiome. Also, breath hydrogen levels, plasma short-chain fatty acids, intestinal integrity and intestinal transit time were not affected. The whole grain diet did, however, compared with the refined grain diet, decrease body weight (p<0.0001), serum inflammatory markers, interleukin (IL)-6 (p=0.009) and C-reactive protein (p=0.003). The reduction in body weight was consistent with a reduction in energy intake, and IL-6 reduction was associated with the amount of whole grain consumed, in particular with intake of rye. CONCLUSION: Compared with refined grain diet, whole grain diet did not alter insulin sensitivity and gut microbiome but reduced body weight and systemic low-grade inflammation. TRIAL REGISTRATION NUMBER: NCT01731366; Results.


Assuntos
Microbioma Gastrointestinal , Inflamação/sangue , Redução de Peso , Grãos Integrais , Adulto , Idoso , Glicemia/metabolismo , Estudos Cross-Over , Dinamarca , Dieta , Ingestão de Energia , Fezes/microbiologia , Feminino , Humanos , Inflamação/dietoterapia , Resistência à Insulina , Interleucina-6/sangue , Lipídeos/sangue , Masculino , Metabolômica , Pessoa de Meia-Idade
2.
Sci Rep ; 10(1): 20103, 2020 11 18.
Artigo em Inglês | MEDLINE | ID: mdl-33208769

RESUMO

Diet is an important component in weight management strategies, but heterogeneous responses to the same diet make it difficult to foresee individual weight-loss outcomes. Omics-based technologies now allow for analysis of multiple factors for weight loss prediction at the individual level. Here, we classify weight loss responders (N = 106) and non-responders (N = 97) of overweight non-diabetic middle-aged Danes to two earlier reported dietary trials over 8 weeks. Random forest models integrated gut microbiome, host genetics, urine metabolome, measures of physiology and anthropometrics measured prior to any dietary intervention to identify individual predisposing features of weight loss in combination with diet. The most predictive models for weight loss included features of diet, gut bacterial species and urine metabolites (ROC-AUC: 0.84-0.88) compared to a diet-only model (ROC-AUC: 0.62). A model ensemble integrating multi-omics identified 64% of the non-responders with 80% confidence. Such models will be useful to assist in selecting appropriate weight management strategies, as individual predisposition to diet response varies.


Assuntos
Dietoterapia/métodos , Microbioma Gastrointestinal , Redução de Peso , Biomarcadores/sangue , Biomarcadores/urina , Feminino , Estudo de Associação Genômica Ampla , Humanos , Aprendizado de Máquina , Masculino , Período Pós-Prandial , Curva ROC , Ensaios Clínicos Controlados Aleatórios como Assunto , Reprodutibilidade dos Testes , Resultado do Tratamento , Grãos Integrais
3.
Nat Commun ; 9(1): 4630, 2018 11 13.
Artigo em Inglês | MEDLINE | ID: mdl-30425247

RESUMO

Adherence to a low-gluten diet has become increasingly common in parts of the general population. However, the effects of reducing gluten-rich food items including wheat, barley and rye cereals in healthy adults are unclear. Here, we undertook a randomised, controlled, cross-over trial involving 60 middle-aged Danish adults without known disorders with two 8-week interventions comparing a low-gluten diet (2 g gluten per day) and a high-gluten diet (18 g gluten per day), separated by a washout period of at least six weeks with habitual diet (12 g gluten per day). We find that, in comparison with a high-gluten diet, a low-gluten diet induces moderate changes in the intestinal microbiome, reduces fasting and postprandial hydrogen exhalation, and leads to improvements in self-reported bloating. These observations suggest that most of the effects of a low-gluten diet in non-coeliac adults may be driven by qualitative changes in dietary fibres.


Assuntos
Dieta , Microbioma Gastrointestinal , Glutens/administração & dosagem , Glutens/efeitos adversos , Adulto , Idoso , Índice de Massa Corporal , Creatinina/urina , Estudos Cross-Over , Citocinas/sangue , DNA Bacteriano/análise , Dinamarca , Jejum , Fezes/microbiologia , Feminino , Fermentação , Microbioma Gastrointestinal/genética , Humanos , Hidrogênio , Intestinos/microbiologia , Masculino , Metabolômica , Metagenômica , Pessoa de Meia-Idade , Período Pós-Prandial , Autorrelato , Adulto Jovem
4.
Nat Microbiol ; 1(9): 16093, 2016 Jun 27.
Artigo em Inglês | MEDLINE | ID: mdl-27562254

RESUMO

Little is known about how colonic transit time relates to human colonic metabolism and its importance for host health, although a firm stool consistency, a proxy for a long colonic transit time, has recently been positively associated with gut microbial richness. Here, we show that colonic transit time in humans, assessed using radio-opaque markers, is associated with overall gut microbial composition, diversity and metabolism. We find that a long colonic transit time associates with high microbial richness and is accompanied by a shift in colonic metabolism from carbohydrate fermentation to protein catabolism as reflected by higher urinary levels of potentially deleterious protein-derived metabolites. Additionally, shorter colonic transit time correlates with metabolites possibly reflecting increased renewal of the colonic mucosa. Together, this suggests that a high gut microbial richness does not per se imply a healthy gut microbial ecosystem and points at colonic transit time as a highly important factor to consider in microbiome and metabolomics studies.


Assuntos
Microbioma Gastrointestinal , Trânsito Gastrointestinal , Metaboloma , Adulto , Idoso , Biomarcadores/metabolismo , Metabolismo dos Carboidratos , Colo/metabolismo , Fezes/microbiologia , Feminino , Fermentação , Humanos , Masculino , Metabolismo , Pessoa de Meia-Idade , Mucosa/metabolismo , Proteínas/metabolismo , Reprodutibilidade dos Testes , Adulto Jovem
5.
APMIS ; 121(1): 38-44, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23030299

RESUMO

To evaluate if heterogeneity of tissue cancer antigen 125 (CA125) expression is present in epithelial serous adenocarcinomas. Furthermore, to investigate whether there is a correlation between levels of CA125 tissue expression, serum level of CA125, stage, and grade. A total of 10 patients diagnosed with serous ovarian adenocarcinomas were included. Preoperative blood samples were collected to determine serum CA125 levels. Tumor tissue from primary surgery was collected and processed for immunohistochemical analyses. CA125 was expressed in varying degrees in tumor tissues from all patients. Mean tissue CA125 expression for each patient ranged from 36% to 98%. Intrapatient variations in tissue expression ranged from 10% to 90% point. No significant correlations between levels of CA125 tissue expression, serum level of CA125, stage, and grade were found. We found that the tissue expression of CA125 is heterogenic. Although most patients had a high mean expression, it covers a large intrapatient variation in expression. This suggests that if using CA125 as a tissue marker and anti-CA125 (oregovomab) as immunotherapy treatment in future studies, it will be necessary to take heterogeneity into consideration and examine a larger number of biopsies. Therefore, the study demonstrates the need for heterogeneity studies in future translational research.


Assuntos
Adenocarcinoma/sangue , Biomarcadores Tumorais/biossíntese , Antígeno Ca-125/biossíntese , Neoplasias Ovarianas/sangue , Adenocarcinoma/patologia , Idoso , Idoso de 80 Anos ou mais , Biomarcadores Tumorais/sangue , Antígeno Ca-125/sangue , Feminino , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Neoplasias Ovarianas/patologia , Estatísticas não Paramétricas , Análise Serial de Tecidos
6.
Ugeskr Laeger ; 171(48): 3505-9, 2009 Nov 23.
Artigo em Dinamarquês | MEDLINE | ID: mdl-19944049

RESUMO

In October 2007, the Danish government and regions made an agreement comprising acute treatment of ovarian cancer (OC) patients. The acute OC-package includes the tumour marker cancer antigen 125 (CA125) as an essential factor. This marker is yet not optimal due to too low sensitivity/specificity. There is therefore a need for new or supplementary markers to improve the treatment. As the agreement will be influencing all diagnostic procedures, there is, furthermore, a need for information about OC and tumor markers. In this article we review the literature and illustrate future challenges and opportunities in OC marker diagnostics.


Assuntos
Biomarcadores Tumorais/análise , Antígeno Ca-125/análise , Neoplasias Ovarianas/diagnóstico , Quimioterapia Adjuvante , Feminino , Predisposição Genética para Doença , Humanos , Programas de Rastreamento , Neoplasias Ovarianas/imunologia , Neoplasias Ovarianas/cirurgia , Medicina de Precisão , Sensibilidade e Especificidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA